Reaction profile

The FDA adverse-event record for perinatal mortality nos

Name: Perinatal mortality NOS - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

31 FDA reports name perinatal mortality nos, a lower-volume reaction in the CVM extract (VeDDRA 783). Plate stamps and neighbourhood peers follow.

#1980 of 2,481
by report volume (all reactions): 31
reports citing this reaction: 83.9%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Perinatal mortality NOS has 31 reports now versus 31 in that prior snapshot: 0 the same number of (0.0%).

Report change: +0
Death-coded reports: +0
Death-coded share: −0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Perinatal mortality NOS changes

FDA AER · VeDDRA plate

Code 783 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 31 reports
DEATH-HOT 83.9%
LOWER-Q #1980/2481
PHOTO-FINISH ABNORMAL TEST RESULT,…
SPECIES-DOG Dog · 21
DRUG-LEAD Spinosad · 10
DESK-WIDE 20 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: ABNORMAL TEST RESULT, THYROID NOS (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Perinatal mortality NOS

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around Perinatal mortality NOS

Perinatal mortality NOS: high death-coded share in the FDA AER plate

Signature read: Perinatal mortality NOS's 83.9% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 31 named reports in the openFDA extract. Death-coded share is upper-third: 26 of 31 reports (83.9% of named reports). Nearest volume peer: ABNORMAL TEST RESULT, THYROID NOS (±0 reports). Lead species Dog (21). Lead co-reported drug Spinosad (10).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 21

Cattle 4

Horse 2

Pig 2

Cat 1

Sheep 1

Breeds Most Affected

Dog (unknown) 5

Pug 5

Crossbred Bovine/Cattle 2

Retriever - Labrador 2

Domestic (unspecified) 1

Terrier - Boston 1

Sheep (unknown) 1

Crossbred Canine/dog 1

Terrier - Yorkshire 1

Boxer (German Boxer) 1

Associated Drugs

Spinosad 10

Ivermectin, Pyrantel Pamoate, Praziquantel 4

Ivermectin 2

Spinosad, Milbemycin 2

Deracoxib 1

Imidacloprid, Moxidectin 1

Tiletamine, Zolazepam 1

Florfenicol 1

Firocoxib 1

Milbemycin, Lufenuron 1

Diclofenac 1

Novobiocin, Penicillin G Procaine 1

Fenbendazole 1

Monensin Sodium 1

Tilmicosin 1

Lufenuron + Milbemycin Oxime 1

Alfaxalone 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Perinatal mortality NOS (#1980 of 2,481 by report volume); death-coded 83.9%. PlainBreed reaction plate · death-coded share stamp 83.9% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →